CSTB and hepatocellular carcinoma: Finally, the observation that CSTB overexpression only partially reversed the tumour‐suppressive effects of ATRA suggests that ATRA likely exerts its anti‐HCC activity through mechanisms beyond the CSTB/CYTB axis.